# Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial

> **NCT06456983** · NA · RECRUITING · sponsor: **Central Institute of Mental Health, Mannheim** · enrollment: 140 (estimated)

## Conditions studied

- Schizophrenia
- Treatment Resistant Schizophrenia

## Interventions

- **DEVICE:** maintenance electroconvulsive therapy (mECT)

## Key facts

- **NCT ID:** NCT06456983
- **Lead sponsor:** Central Institute of Mental Health, Mannheim
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-14
- **Primary completion:** 2027-07
- **Final completion:** 2028-07
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06456983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06456983, "Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06456983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*